Skip to main content

Group Drumming Intervention in Reducing Fatigue, Anxiety, and Cognitive Impairment in Cancer Patients

Trial Status: Active

This trial studies how well group drumming intervention works in reducing fatigue, anxiety, and cognitive impairment in cancer patients. Group drumming intervention during cancer treatment may reduce fatigue, anxiety, and cognitive impairment and improve the well-being and quality of life of cancer patients.

Inclusion Criteria

  • Adult engaged in active cancer treatment (newly diagnosed or new reoccurence) who have received at least one session of chemotherapy or radiation treatment and self-report symptoms of fatigue or anxiety at a level 4 or above on a scale of 0-10
  • At least one week after surgery
  • Ability to read and write in English

Exclusion Criteria

  • Total deafness or severely impaired hearing
  • Absence of arms and/or hands
  • Current engagement in group drumming
  • Scheduled for surgery in the next 12 weeks
  • Currently taking medications for diagnosis of dementia or Alzheimer’s disease
  • Substantial, uncorrected vision loss


Salt Lake City
Huntsman Cancer Institute / University of Utah
Status: ACTIVE
Contact: Shelley White
Phone: 801-755-3680


I. To evaluate the feasibility of a six-week group drumming intervention for cancer patients who have undergone at least one treatment session of chemotherapy or radiation therapy.


I. To provide preliminary data on the impact of the intervention on fatigue and anxiety when compared to an attentional control.


I. To explore whether cancer patients, who participate in a 6-week group drumming intervention, will show improvement in cognitive function, as measured by the Functional Assessment of Cancer Therapy-Cognition (FACT-COG).

OUTLINE: Patients are randomized to 1 of 2 group.

GROUP I: Patients participate in group drumming over 1 hour on days 1, 2, and 3 for 6 weeks.

GROUP II: Patients view an interesting educational series over 1 hour on days 1, 2, and 3 for 6 weeks.

Trial Phase Phase NA

Trial Type Supportive care

Lead Organization
Huntsman Cancer Institute / University of Utah

Principal Investigator
Shelley White

  • Primary ID HCI116181
  • Secondary IDs NCI-2018-03027
  • ID NCT03955003